Hi, has anyone heard of this medicine for increasing plalets?
GlaxoSmithKline, Britain’s largest pharmaceuticals group, this week plans to unveil details of a breakthrough cancer drug that could be a potential blockbuster generating billions of pounds of sales for the company.
The group will use a research seminar to present data on a potential treatment for low blood platelet count, which is associated with liver failure and chemotherapy. At the moment, patients suffering from the disease either have to undergo a blood transfusion or have their spleen removed. If GSK’s product is successful, those treatments could be replaced by a tablet.
The drug, called eltrombopag, is still in the early stages of development.
GSK is believed to have started talks with the Food & Drug Administration, the US medicines regulator, about getting it approved. Analysts say the product could be launched as early as the middle of 2007 being studied in England. This was from Nov. 2005, and I haven’t heard anything about it since. Thanks, Bernard and Bonnie